Samsara BioCapital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,669
| Closed | -$55.8K | – | 55 |
|
|
2023
Q1 | $55.8K | Hold |
13,669
| – | – | 0.01% | 54 |
|
|
2022
Q4 | $68.6K | Hold |
13,669
| – | – | 0.01% | 52 |
|
|
2022
Q3 | $179K | Hold |
13,669
| – | – | 0.04% | 52 |
|
|
2022
Q2 | $175K | Hold |
13,669
| – | – | 0.05% | 53 |
|
|
2022
Q1 | $208K | Hold |
13,669
| – | – | 0.05% | 54 |
|
|
2021
Q4 | $242K | Hold |
13,669
| – | – | 0.05% | 47 |
|
|
2021
Q3 | $287K | Sell |
13,669
-4,556
| -25% | -$95.7K | 0.05% | 44 |
|
|
2021
Q2 | $359K | Hold |
18,225
| – | – | 0.04% | 46 |
|
|
2021
Q1 | $530K | Hold |
18,225
| – | – | 0.1% | 40 |
|
|
2020
Q4 | $552 | Sell |
18,225
-18,226
| -50% | -$552 | 0.06% | 42 |
|
|
2020
Q3 | $580K | Sell |
36,451
-12,151
| -25% | -$193K | 0.16% | 35 |
|
|
2020
Q2 | $959K | Buy |
+48,602
| New | +$959K | 0.31% | 28 |
|